Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.
about
Are we closer to seeing carcinoma in situ in the upper urinary tract?Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladderCurrent perspectives in bladder cancer managementApproaching the optimal transurethral resection of a bladder tumorDefining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancerAdvances in imaging technologies in the evaluation of high-grade bladder cancerEmerging endoscopic imaging technologies for bladder cancer detectionDiagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysisEffects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysisContemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.New frontier in hypericin-mediated diagnosis of cancer with current optical technologies.The role of transcavitary ultrasonography in diagnosis and staging of nonmuscle-ınvasive bladder cancer: a prospective non-randomized clinical study.Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trialsNarrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rateNeurotensin branched peptide as a tumor-targeting agent for human bladder cancer.A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer: A feasibility and dose finding study.Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancerHIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies - after photodynamic diagnosis (PDD).Contemporary management of low-risk bladder cancer.The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature.Recent advances in urinary bladder cancer detection.Current strategies in the treatment of non-muscle-invasive bladder cancer.High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment.Is photodynamic diagnosis ready for introduction in urological clinical practice?Strategies to improve quality of life in bladder cancer patients.Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and futurRole of Narrow Band Imaging in Management of Urothelial Carcinoma.Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.New developments in the management of nonmuscle invasive bladder cancer.Fluorescence Imaging for Cancer Screening and Surveillance.Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies.Use of fluorescein isothiocyanate-human serum albumin for the intravesical photodiagnosis of non-muscle-invasive bladder cancer: an in vitro study using multicellular spheroids composed of normal human urothelial and urothelial cell carcinoma cell lPotential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract.
P2860
Q26739728-60D9100D-7C86-4A48-8EF6-9BA215C3A351Q26744756-F806FFBA-9306-4DC7-A71B-6E1CEBEBB1B6Q26775775-28881EAE-3E1B-4A9D-8016-2B25D905FFE5Q26824914-4E568C0A-9685-4A94-A4FB-948648A3FA5AQ26829828-23FBAB1F-4556-4288-B6AC-FF7AA2CDB346Q26852084-F5B3E008-C747-4A17-B889-74EF3E0917E0Q26852856-20CF5F5D-CC60-4999-8CC2-CCB834427ACCQ26853736-647ED5BE-DB9F-4187-A4AD-CD112768745EQ26859123-E7BF3017-179F-4744-976B-D397F3050203Q26866103-DEB71D6D-80C5-4350-9A42-91D44389FA87Q33803794-28DA2229-4E70-4358-9B87-A845245F8636Q34075838-F02AA3F2-A42A-436E-96A7-373ACEA4D312Q34085422-2EAF8584-F93F-4B81-9FBA-57F7B1AE5062Q34206810-9AE70FF3-B122-4EF2-8827-1CCB625649C1Q34994530-FF0C5D13-C128-4643-8311-61642056DF48Q35127220-714A14CB-C56A-47E9-998D-5C53DCDD19D1Q35578796-BF61B441-42B6-4507-9AC6-D72D4F8C21E3Q35732445-A93056EE-88ED-4F7D-A87A-52795FC35F20Q36196629-0E6E3EF0-C9AD-4621-9FFC-24A52634D086Q37053829-65941007-F9C0-41E2-B68A-32068F8E2CD2Q37476699-B5D91F21-232A-4B5D-B2C0-D32EFB6A0E73Q37579133-AB3E122E-C986-4DBE-BB1B-E46EE2221BC7Q37828064-A21C39CB-3AEF-424C-B985-E7475B6A3959Q37903407-C3EF39B2-2C83-4AC5-86FB-DA2461B050FAQ37911276-BA5C485C-8886-4507-91F5-7486D1734A96Q38030593-D7E608D8-E627-41FC-B768-202E106B59AAQ38048823-B067AB19-14BA-444B-96D3-E765EA321ABEQ38052445-CE334AE6-3BF3-41BF-B1FD-80A224B1B6F5Q38114946-6EC3BE72-3190-48ED-86D9-3AE0407B5CE5Q38210653-EFA41155-AD60-45AE-9070-9AA0E8681F81Q38253205-5BF86AE8-C079-4760-8652-3039587F1DCBQ38342245-A874444E-CA65-4959-8EFA-E13D4E1B8F48Q38533132-BCBAB862-201B-42DA-A959-826AF4D5A7BBQ38639727-9CFA0FA5-80AB-481D-B409-066F416E0576Q38742159-E6C499BA-6CD5-4C2C-B40D-341D87407921Q38914895-1EB05D7B-FAFF-4551-B283-6F3EEC82BFA0Q39117047-5AC0F67A-55A1-4553-9860-6A7775A6B087Q39173709-5129A78F-2059-4012-82E0-7E593C9847A1Q39620375-443AC9E3-E947-4411-9B21-41F801075BEFQ40002203-12F23A06-777F-4AA8-AF72-67A349E94ADF
P2860
Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@ast
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@en
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@nl
type
label
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@ast
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@en
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@nl
prefLabel
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@ast
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@en
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@nl
P2093
P1433
P1476
Photodynamic diagnosis in non- ...... alysis of prospective studies.
@en
P2093
Arnulf Stenzl
Didier Jacqmin
Dieter Jocham
Ingo Kausch
Martin Sommerauer
Patrice Jichlinski
Reinhard Vonthein
P304
P356
10.1016/J.EURURO.2009.11.041
P407
P577
2009-12-02T00:00:00Z